ATE193553T1 - Domänen von extrazellulären bereichen von menschlichen blutplättchen abstammenden wachstumsfaktor rezeptor-polypeptiden - Google Patents

Domänen von extrazellulären bereichen von menschlichen blutplättchen abstammenden wachstumsfaktor rezeptor-polypeptiden

Info

Publication number
ATE193553T1
ATE193553T1 AT92906305T AT92906305T ATE193553T1 AT E193553 T1 ATE193553 T1 AT E193553T1 AT 92906305 T AT92906305 T AT 92906305T AT 92906305 T AT92906305 T AT 92906305T AT E193553 T1 ATE193553 T1 AT E193553T1
Authority
AT
Austria
Prior art keywords
growth factor
derived growth
factor receptor
platele
domain
Prior art date
Application number
AT92906305T
Other languages
English (en)
Inventor
Jaime A Escobedo
Lewis T Williams
David Wolf
James E Tomlinson
Larry J Fretto
Neill A Giese
Original Assignee
Cor Therapeutics Inc
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cor Therapeutics Inc, Univ California filed Critical Cor Therapeutics Inc
Application granted granted Critical
Publication of ATE193553T1 publication Critical patent/ATE193553T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT92906305T 1991-01-31 1992-01-28 Domänen von extrazellulären bereichen von menschlichen blutplättchen abstammenden wachstumsfaktor rezeptor-polypeptiden ATE193553T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65079391A 1991-01-31 1991-01-31
PCT/US1992/000730 WO1992013867A1 (en) 1991-01-31 1992-01-28 Domains of extracellular region of human platelet derived growth factor receptor polypeptides

Publications (1)

Publication Number Publication Date
ATE193553T1 true ATE193553T1 (de) 2000-06-15

Family

ID=24610314

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92906305T ATE193553T1 (de) 1991-01-31 1992-01-28 Domänen von extrazellulären bereichen von menschlichen blutplättchen abstammenden wachstumsfaktor rezeptor-polypeptiden

Country Status (13)

Country Link
US (3) US5686572A (de)
EP (1) EP0584082B1 (de)
JP (1) JPH06507543A (de)
AT (1) ATE193553T1 (de)
AU (2) AU1411092A (de)
CA (1) CA2100559C (de)
DE (1) DE69231128T2 (de)
DK (1) DK0584082T3 (de)
ES (1) ES2147729T3 (de)
GR (1) GR3034267T3 (de)
IE (1) IE920317A1 (de)
NZ (1) NZ241480A (de)
WO (1) WO1992013867A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE920318A1 (en) * 1991-01-31 1992-07-29 Univ California Human platelet-derived growth factor receptors
EP0584082B1 (de) * 1991-01-31 2000-05-31 Cor Therapeutics, Inc. Domänen von extrazellulären bereichen von menschlichen blutplättchen abstammenden wachstumsfaktor rezeptor-polypeptiden
US20020009443A1 (en) * 1991-12-02 2002-01-24 Vanitha Ramakrishman Inhibitory immunoglobulin polypeptides to human pdgf beta receptor
US5817310A (en) * 1991-12-02 1998-10-06 Cor Therapeutics, Inc. Inhibitory immunoglobulin polypeptides to human PDGF beta receptor
PL171788B1 (pl) * 1991-12-02 1997-06-30 Cor Therapeutics Inc wykazujacego aktywnosc wiazania receptora ludzkiego czynnika wzrostupochodzacego z plytek PL PL PL
US6824777B1 (en) 1992-10-09 2004-11-30 Licentia Ltd. Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
US5776755A (en) * 1992-10-09 1998-07-07 Helsinki University Licensing, Ltd. FLT4, a receptor tyrosine kinase
US6107046A (en) * 1992-10-09 2000-08-22 Orion Corporation Antibodies to Flt4, a receptor tyrosine kinase and uses thereof
US20040002117A1 (en) * 1998-02-12 2004-01-01 Hogan Patrick G. Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases
JP4841724B2 (ja) 1998-10-09 2011-12-21 ベジェニクス ピーティーワイ リミテッド 腫瘍イメージングおよび抗腫瘍治療の標的としてのＦｌｔ４（ＶＥＲＧ−３）
NZ516258A (en) * 1999-06-07 2004-02-27 Immunex Corp Tek antagonists
US6667173B2 (en) 2000-12-01 2003-12-23 The Schepens Eye Research Institute Nucleic acids encoding platelet derived growth factor-alpha receptors
JP4669984B2 (ja) 2001-01-19 2011-04-13 ベジェニクス リミテッド 腫瘍画像化のターゲットとしてのＦ１ｔ４（ＶＥＧＦＲ−３）および抗腫瘍療法
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
CA2488876A1 (en) 2002-06-13 2003-12-24 Oregon Health & Science University Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets
US20050239088A1 (en) * 2003-05-16 2005-10-27 Shepard H M Intron fusion proteins, and methods of identifying and using same
NZ592039A (en) 2003-08-27 2013-03-28 Ophthotech Corp Combination therapy for the treatment of ocular neovascular disorders
EP1745073A2 (de) * 2004-05-14 2007-01-24 Receptor Biologix, Inc. Isoformen eines zelloberflächenrezeptors und verfahren zu deren identifizierung und anwendung
US20060234347A1 (en) * 2005-04-13 2006-10-19 Harding Thomas C Targeting multiple angiogenic pathways for cancer therapy using soluble tyrosine kinase receptors
US20090170769A1 (en) * 2005-05-13 2009-07-02 Pei Jin Cell surface receptor isoforms and methods of identifying and using the same
CA2678008C (en) 2005-06-17 2013-07-30 Imclone Systems Incorporated Methods of treating a secondary bone tumor with anti-pdgfralpha antibodies
CL2007002225A1 (es) 2006-08-03 2008-04-18 Astrazeneca Ab Agente de union especifico para un receptor del factor de crecimiento derivado de plaquetas (pdgfr-alfa); molecula de acido nucleico que lo codifica; vector y celula huesped que la comprenden; conjugado que comprende al agente; y uso del agente de un
EA019595B1 (ru) * 2007-04-17 2014-04-30 Имклоун Элэлси СПЕЦИФИЧНЫЕ ИНГИБИТОРЫ PDGFRβ
EP2160409A1 (de) * 2007-05-24 2010-03-10 Ablynx N.V. Gegen wachstumsfaktorrezeptoren gerichtete aminosäuresequenzen und diese enthaltende polypeptide zur behandlung von krankheiten und erkrankungen, die mit wachstumsfaktoren und ihren rezeptoren assoziiert sind
EP2155238B1 (de) 2007-06-05 2016-04-06 Yale University Antikörper gegen die d4 domäne des kit rezeptors und anwendungsverfahren
JP5425180B2 (ja) * 2008-03-27 2014-02-26 ザイモジェネティクス， インコーポレイテッド ＰＤＧＦＲβおよびＶＥＧＦ−Ａを阻害するための組成物および方法
US20120189641A1 (en) 2009-02-25 2012-07-26 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
US8642834B2 (en) 2009-02-27 2014-02-04 OSI Pharmaceuticals, LLC Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
WO2010099138A2 (en) 2009-02-27 2010-09-02 Osi Pharmaceuticals, Inc. Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
JP2012519282A (ja) 2009-02-27 2012-08-23 オーエスアイ・ファーマシューティカルズ，エルエルシー 間葉様腫瘍細胞またはその生成を阻害する薬剤を同定するための方法
WO2011075185A1 (en) 2009-12-18 2011-06-23 Oligasis Targeted drug phosphorylcholine polymer conjugates
BR112012033457A2 (pt) 2010-07-02 2017-04-04 Medimmune Llc formulações de anticorpo.
US20120189633A1 (en) 2011-01-26 2012-07-26 Kolltan Pharmaceuticals, Inc. Anti-kit antibodies and uses thereof
JP2014519813A (ja) 2011-04-25 2014-08-21 オーエスアイ・ファーマシューティカルズ，エルエルシー 癌薬剤発見、診断、および治療におけるｅｍｔ遺伝子シグネチャーの使用
WO2013152252A1 (en) 2012-04-06 2013-10-10 OSI Pharmaceuticals, LLC Combination anti-cancer therapy
EP4063391A1 (de) 2012-07-25 2022-09-28 Celldex Therapeutics, Inc. Anti-kit-antikörper und verwendungen davon
JO3405B1 (ar) 2013-01-09 2019-10-20 Regeneron Pharma الأجسام المضادة لمضاد مستقبل عامل النمو المشتق من الصفائح الدموية - بيتا واستخداماتها
MY170528A (en) 2013-02-18 2019-08-09 Vegenics Pty Ltd Vegfr-3 ligand binding molecules and uses thereof
SI2968461T1 (sl) 2013-03-13 2023-01-31 Genzyme Corporation Fuzijski proteini, ki vsebujejo vezavna dela PDGF in VEGF in postopek njihove uporabe
ES2819217T3 (es) 2013-09-08 2021-04-15 Kodiak Sciences Inc Conjugados de polímeros iónicos dipolares y factor VIII
JP6768639B2 (ja) 2014-05-23 2020-10-21 セルデックス セラピューティクス，インコーポレーテッド 好酸球又はマスト細胞関連障害の治療
WO2015200905A2 (en) 2014-06-28 2015-12-30 Oligasis, Llc Dual pdgf/vegf antagonists
EP3207128B1 (de) 2014-10-17 2022-07-27 Kodiak Sciences Inc. Zwitterionische butyrylcholinesterasepolymerkonjugate
IL290457B2 (en) 2015-12-30 2025-02-01 Kodiak Sciences Inc Antibodies and their conjugates
CA3059938A1 (en) 2017-04-14 2018-10-18 Kodiak Sciences Inc. Complement factor d antagonist antibodies and conjugates thereof
CA3092588A1 (en) 2018-03-02 2019-09-06 Kodiak Sciences Inc. Il-6 antibodies and fusion constructs and conjugates thereof
EP4031164A4 (de) * 2019-09-17 2023-10-25 The Board Of Trustees Of The University Of Illinois Gentechnisch veränderte rezeptoren für humanes cytomegalovirus und deren verwendungen
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2092468T3 (es) * 1988-01-22 1996-12-01 Zymogenetics Inc Metodos para producir analogos de receptores secretados.
AU607306B2 (en) * 1988-02-02 1991-02-28 Regents Of The University Of California, The Human platelet-derived growth factor receptor
DK0456766T3 (da) * 1989-02-09 1999-11-08 Us Health Gen for receptor for type alfa-blodplade-afledt vækstfaktor
IL97996A0 (en) * 1990-04-30 1992-06-21 Novo Nordisk As Hybrid cellular receptor
EP0584082B1 (de) * 1991-01-31 2000-05-31 Cor Therapeutics, Inc. Domänen von extrazellulären bereichen von menschlichen blutplättchen abstammenden wachstumsfaktor rezeptor-polypeptiden
IE920318A1 (en) * 1991-01-31 1992-07-29 Univ California Human platelet-derived growth factor receptors
PL171788B1 (pl) * 1991-12-02 1997-06-30 Cor Therapeutics Inc wykazujacego aktywnosc wiazania receptora ludzkiego czynnika wzrostupochodzacego z plytek PL PL PL
DE69233125T2 (de) * 1991-12-02 2004-04-22 Millennium Pharmaceuticals, Inc., South San Francisco Inhibitorische immunglobulin-polypeptide gegen den pdgf beta-rezeptor

Also Published As

Publication number Publication date
CA2100559A1 (en) 1992-08-01
NZ241480A (en) 1993-09-27
DE69231128T2 (de) 2001-02-15
US5891652A (en) 1999-04-06
US5686572A (en) 1997-11-11
DK0584082T3 (da) 2000-10-16
WO1992013867A1 (en) 1992-08-20
AU5580496A (en) 1996-09-19
IE920317A1 (en) 1992-07-29
CA2100559C (en) 2007-05-22
EP0584082B1 (de) 2000-05-31
JPH06507543A (ja) 1994-09-01
US5872218A (en) 1999-02-16
DE69231128D1 (de) 2000-07-06
EP0584082A1 (de) 1994-03-02
AU1411092A (en) 1992-09-07
AU709177B2 (en) 1999-08-26
ES2147729T3 (es) 2000-10-01
EP0584082A4 (en) 1994-08-24
GR3034267T3 (en) 2000-12-29

Similar Documents

Publication Publication Date Title
DE69231128D1 (de) Domänen von extrazellulären bereichen von menschlichen blutplättchen abstammenden wachstumsfaktor rezeptor-polypeptiden
FI903489A7 (fi) Yhden osan sisältävät ligandit, näitä ligandeja sisältävät reseptorit, menetelmiä niiden valmistamiseksi sekä ligandien ja reseptorien käytt ö
DE69931929D1 (de) Peptidantagonisten von zonulin und methoden zu deren verwendung
TR27005A (tr) Yapay malzemeli, katlanabilir sise.
FI961251L (fi) Ihmisten metabotrooppiset glutamaattireseptorialatyypit(HMR4, HMR6, HMR7)ja niihin liittyvät DNA-yhdisteet
DK1140173T4 (da) Vaskulære endothelcellevækstfaktorantagonister og anvendelser deraf
ATE226247T1 (de) Menschliche neuronale nikotin-acetylcholin- rezeptor-verbindungen und methoden ihres einsatzes
ATE255420T1 (de) Verwendung von tumorzellen zeitversetzt in kombination mit intakten antikörpern zur immunisierung
DE69514342D1 (de) Modifizierte polypeptide mit erhoehter biologischer aktivitaet
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
ATE342915T1 (de) Chimäres lösliches interleukin-6 rezeptor/ligand protein, analoge und verwendungen
FI944516L (fi) Fuusioproteiineja, jotka sisältävät kasvainkuoliotekijän reseptoria
YU28897A (sh) Biciklicno kondenzovani piridini
DE3861092D1 (de) Ruthenium-traegerkatalysator, seine herstellung und sein einsatz bei der herstellung von gegebenenfalls substituiertem cyclohexylamin und gegebenenfalls substituiertem dicyclohexylamin.
DE69636437D1 (de) Ligand polypeptide für hypophyse g-protein gekoppeltes rezeptor-protein, deren herstellung und anwendung
TR200002896T2 (tr) Kalsilitik Bileşimler
DE58900694D1 (de) Ruthenium-traegerkatalysator, seine herstellung und sein einsatz bei der herstellung von gegebenenfalls substituiertem cyclohexylamin und gegebenenfalls substituiertem dicyclohexylamin.
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
DE68906462D1 (de) Praeparat aus reiskleie und dessen verwendung.
EE9900146A (et) Lahustuvad lümfotoksiin-ß retseptorid, lümfotoksiini retseptori vastased antikehad ja lümfotoksiini ligandi vastased antikehad terapeutiliste agensitena immunoloogiliste haiguste raviks
ATE225809T1 (de) Vaskulare endothelzelle-wachstumsfaktor antiidotypische antikörper und ihre verwendung als arzneimittel
DE69422611D1 (de) 5-ht1a-liganden
TR199800152T1 (xx) Endotelin Resept�r Antagonistleri
DE58904019D1 (de) Enantiomere silane, modifiziertes traegermaterial und dessen verwendung.
DE69526738D1 (de) Endothelin-rezeptor-antagonisten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee